Clinical implications of deficiencies of protein S, protein C or antithrombin Brouwer, Jan Leendert Pouwel

Transcription

1 University of Groningen Clinical implications of deficiencies of protein S, protein C or antithrombin Brouwer, Jan Leendert Pouwel IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2009 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Brouwer, J. L. P. (2009). Clinical implications of deficiencies of protein S, protein C or antithrombin. Groningen: s.n. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date:

2 appendix d List of publications International publications 1. Brouwer JL, Lijfering WM, Ten Kate MK, Kluin-Nelemans HC, Veeger NJ, van der Meer J. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin. Thromb Haemost. 2009;101(1): Lijfering WM, Brouwer JL, Veeger NJ, Bank I, Coppens M, Middeldorp S, Hamulyák K, Prins MH, Büller HR, van der Meer J. Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood. 2009;113(21): Mahmoodi BK, Brouwer JL, Veeger NJ, van der Meer J. Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study. Circulation. 2008;118(16): Mahmoodi BK, ten Kate MK, Waanders F, Veeger NJ, Brouwer JL, Vogt L, Navis G, van der Meer J. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation. 2008;117(2): Lijfering WM, Veeger NJ, Brouwer JL, van der Meer J. The risk of venous and arterial thrombosis in hyperhomocysteinemic subjects may be a result of elevated factor VIII levels. Haematologica. 2007;92(12): Folkeringa N, Brouwer JL, Korteweg FJ, Veeger NJ, Erwich JJ, van der Meer J. High risk of pregnancy-related venous thromboembolism in women with multiple thrombophilic defects. Br J Haematol. 2007;138(1): Libourel EJ, ten Kate MK, Brouwer JL, Veeger NJ, van der Meer J. Contribution of multiple thrombophilic and transient risk factors in the development of cerebral venous thrombosis. Thromb Res. 2007;121(3):

3 8. van Vlijmen EF, Brouwer JL, Veeger NJ, Eskes TK, de Graeff PA, van der Meer J. Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study. Arch Intern Med. 2007;167(3): Folkeringa N, Brouwer JL, Korteweg FJ, Veeger NJ, Erwich JJ, Holm JP, van der Meer J. Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women. Br J Haematol. 2007;136(4): Lijfering WM, Veeger NJ, Brouwer JL, van de Poel MH, van der Meer J. Methionine-loading and random homocysteine tests have no added value in risk assessment for venous and arterial thrombosis. J Thromb Haemost. 2007;5(3): Brouwer JL, Veeger NJ, Kluin-Nelemans HC, van der Meer J. The pathogenesis of venous thromboembolism: evidence for multiple interrelated causes. Ann Intern Med. 2006;145(11): ten Kate MK, Mulder R, Platteel M, Brouwer JL, van der Steege G, van der Meer J. Identification of a novel PROS1 c.1113t-->gg frameshift mutation in a family with mixed type I/type III protein S deficiency. Haematologica. 2006;91(8): Brouwer JL, Veeger NJ, van der Schaaf W, Kluin-Nelemans HC, van der Meer J. Difference in absolute risk of venous and arterial thrombosis between familial protein S deficiency type I and type III. Results from a family cohort study to assess the clinical impact of a laboratory test-based classification. Br J Haematol. 2005;128(5): Brouwer JL, Bijl M, Veeger NJ, Kluin-Nelemans HC, van der Meer J. The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus. Blood. 2004;104(1): Oude Elberink JN, de Monchy JG, Golden DB, Brouwer JL, Guyatt GH, Dubois AE. Development and validation of a health-related quality-of-life questionnaire in patients with yellow jacket allergy. J Allergy Clin Immunol. 2002;109(1): Abstracts 16. Folkeringa N, Brouwer JL, Veeger NJ, van der Meer J. Increased TAFI levels and the risk of thromboembolism. Thromb Haemost. 2007;S(1):

4 17. Folkeringa N, Brouwer JL, Korteweg FJ, Veeger NJ, Erwich JJHM, van der Meer J. High Risk of Pregnancy Related Venous Thromboembolism in Women with a Hereditary Deficiency of Antithrombin, Protein C or Protein S in Concomitance of Other Thrombophilic Defects: A Retrospective Cohort Study. Blood 2006;108: Folkeringa N, Brouwer JL, Korteweg FJ, Veeger NJ, Erwich JJHM, van der Meer J. Risk of Venous Thromboembolism Is Not Increased by Elevated TAFI Levels. Blood 2006;108: Lijfering WM, Veeger NJ, Brouwer JL, Van de Poel MHW, van der Meer J. Methionine-Loading and Random Homocysteine Tests Have No Added Value in Risk Assessment for Venous and Arterial Thrombosis. Blood 2006;108: Lijfering WM, Veeger NJ, Brouwer JL, Van de Poel MHW, van der Meer J. The Risk of Venous and Arterial Thrombosis in Hyperhomocysteinemic Subjects Is Caused by Elevated Factor VIII:C Levels. Blood 2006;108: Brouwer JL, Veeger NJ, Ten Kate MK, Van der Schaaf W, Kluin-Nelemans HC, van der Meer J. Hereditary Deficiencies of Protein C, Protein S and Antithrombin Protect Against Bleeding During Anticoagulant Treatment. Results From a Family Cohort Study (DESCARTES). Thromb Haemost. 2005;3(S1): Brouwer JL, Veeger NJ, Ten Kate MK, Van der Schaaf W, Kluin-Nelemans HC, van der Meer J. A Prospective Study to Assess The Absolute Incidence of Venous Thromboembolism (VTE) Associated with Hereditary Deficiencies of Protein C, Protein S and Antithrombin and the Contribution of Cosegregation of other Mild Thrombophilic Defects. Thromb Haemost. 2005;3(S1): Brouwer JL, Veeger NJ, Ten Kate MK, Van der Schaaf W, Kluin-Nelemans HC, van der Meer J. Risk of Recurrent Venous Thromboembolism (VTE) Associated with Hereditary Deficiencies of Protein C, Protein S and Antithrombin Depends on Cosegregation with other Thrombophilic Disorders. A Prospective Family Cohort Study. Thromb Haemost. 2005;3(S1): Brouwer JL, Veeger NJ, Ten Kate MK, Van der Schaaf W, Kluin-Nelemans HC, van der Meer J. Absolute Risk of Venous Thromboembolism (VTE) Associated with Hereditary Deficiencies of Protein C, Protein S or Antithrombin Strongly Depends on Cosegregation of Other Thrombophilic Disorders. A Retrospective Family Cohort Study (DESCARTES) Thromb Haemost. 2005;3(S1): Brouwer JL, Veeger NJ, Ten Kate MK, Van der Schaaf W, Kluin-Nelemans HC, van der Meer J. Random homocystein measurements can be used to avoid oral methionine tolerance testing. Thromb Haemost. 2005;3(S1):

5 26. Folkeringa N, Brouwer JL, Korteweg FJ, Veeger NJ, Erwich JJHH, Holm JP, van der Meer J. Reduction Of Fetal Loss Rate by Anticoagulant Treatment During Pregnancy In Women With Hereditary Deficiency of Antithrombin, Protein C or Protein S type I. A Prospective Study. Thromb Haemost. 2005;3(S1): Korteweg FJ, Brouwer JL, Folkeringa N, Veeger NJ, Erwich JJHM, Holm JP, van der Meer J. Fetal Loss In Hereditary Antithrombin, Protein C And Protein S Deficiencies. Thromb Haemost. 2005;3(S1): Vlijmen van EFW, Brouwer JL, Veeger NJ, De Graeff PA, van der Meer J. High Risk Of Venous Thromboembolism (VTE) Associated With Oral Contraceptives In Women With Hereditary Deficiencies Of Protein S, Protein C Or Antithrombin Is Due To Acceleration Rather Than Overall Increased Risk. A Retrospective Family Cohort Study. (DESCARTES). Thromb Haemost. 2005;3(S1): Vlijmen van EFW, Brouwer JL, Veeger NJ, De Graeff PA, van der Meer J. Absolute Risk Of Venous Thromboembolism (VTE) Associated With Oral Contraceptives In Women With Hereditary Deficiencies Of Protein S, Protein C Or Antithrombin Strongly Depends On Cosegregation Of Thrombophilic Disorders. A Retrospective Family Cohort Study. (DESCARTES). Thromb Haemost. 2005;3(S1): Ten Kate MK, Brouwer JL, Veeger NJ, van der Meer J. Protein C/S Ratio Improves Accuracy To Identify Hereditary Protein S Deficiency Type I. Results From A Family Cohort Study. (DESCARTES). Thromb Haemost. 2005;3(S1): Ten Kate MK, Brouwer JL, Veeger NJ, van der Meer J. Protein C/S Ratio To Identify Protein S Type I Non-Deficient Relatives At High Risk Of Venous Thromboembolism (VTE). Results From A Family Cohort Study (DESCARTES) Thromb Haemost. 2005;3(S1): Ten Kate MK, Brouwer JL, Sprenger HG, van der Meulen PA, van der Meer J. Effects Of Highly Active Antiretroviral Therapy On The Risk Of Venous And Arterial Thromboembolism In Male And Female HIV Positive Patients. Thromb Haemost. 2005;3(S1): Vogt L, Brouwer JL, Ten Kate MK, Navis GJ, van der Meer J. Absolute Risk Of Venous Thromboembolism (VTE) Associated With Nephrotic Syndrome. Results From The Coltrane Study. Thromb Haemost. 2005;3(S1): Vogt L, Brouwer JL, Ten Kate MK, van der Meer J, Navis GJ. Absolute Risk Of Arterial Thromboembolism (ATE) Associated With Nephrotic Syndrome. Results From The Coltrane Study. Thromb Haemost. 2005;3(S1):

6 35. Ten Kate MK, Brouwer JL, Veeger NJ, van der Meer J. Difference in absolute risk of venous and arterial thrombosis between familial protein S deficiency type I and type III. Results from a family cohort study to assess the clinical impact of a laboratory test-based classification and the value of protein C/S ratio to identify relatives at high risk of venous thromboembolism. ISCOMS. 2005; Brouwer JL, Veeger NJ, van der Schaaf W, Kluin-Nelemans HC, van der Meer J. Hereditary Protein S Type III Deficiency Is Not a Risk Factor for Venous and Arterial Thrombosis, in Contrast to Protein S Deficiency Type I. Results from a Family Cohort Study To Assess the Clinical Impact of a Laboratory Based Classification. Blood 2004;104; Brouwer JL, Veeger NJ, van der Schaaf W, Kluin-Nelemans HC, van der Meer J. Inherited protein S deficiency type I, but not type III is a risk factor for venous, but not arterial thrombosis: a study in 81 families. Pathofys Haemost Thromb. 2004;33(S2): Brouwer JL, Veeger NJ, van der Schaaf W, Kluin-Nelemans HC, van der Meer J. Inherited protein S deficiency type I, but not type III is a risk factor for venous thrombosis. International Angiology. 2004;23(S1): Brouwer JL, Bijl M, Kluin-Nelemans HC, van der Meer J. Venous thromboembolism (VTE) in patients with systemic lupus erythematosus (SLE): the contribution of inherited thrombophilic risk factors. Thromb Haemost. 2003;1(S1): Brouwer JL, Bijl M, Kluin-Nelemans HC, van der Meer J. Arterial thromboembolism (ATE) in patients with systemic lupus erythematosus (SLE): the contribution of inherited thrombophilic risk factors. Thromb Haemost. 2003;1(S1): Meijer K, Brouwer JL, Hendriks HGD, De Wolf JGM, Klompmaker IJ, Lisman T, Hagenaars AAM, Slooff MJH, Porte RJ, van der Meer J. Recombinant factor VIIa in orthotopic liver transplantation: influence on parameters of coagulation and fibrinolysis. Thromb Haemost. 2001;1(S1): Brouwer JL, Van der Molen T, Meyboom-De Jong B, Postma DS. Validity and reliability of the Dutch version of the Twenty Item Asthma Questionnaire (AQ20). Eur Resp J ;12(S28):

7 Other publications 43. Brouwer JLP. Medisch begeleid zelfdoseren van antistollingsmedicatie via internet. ICD-Journaal. 2008;2: Brouwer JLP and van der Meer J. Hereditary protein S deficiency type III is not a risk factor for venous and arterial thrombosis, in contrast to protein S deficiency type I. Results from a family cohort study to assess the clinical impact of a laboratory test based classification. Phlebology Digest. 2006; Brouwer JLP. Inhibitors in congenital clottingfactordefects. Hemophilia congress review. American Society of Hematology. 2004;1: Brouwer JLP, van der Meer J. Leverziekten en stolling. Hematologie Actueel. 2000;3:

8